nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—CYP3A4—Clindamycin—malaria	0.149	0.214	CbGbCtD
Dihydroergotamine—CYP3A4—Sulfadiazine—malaria	0.0854	0.123	CbGbCtD
Dihydroergotamine—ABCB1—Quinine—malaria	0.0734	0.106	CbGbCtD
Dihydroergotamine—CYP3A4—Artemether—malaria	0.0726	0.105	CbGbCtD
Dihydroergotamine—CYP3A4—Proguanil—malaria	0.0682	0.0984	CbGbCtD
Dihydroergotamine—CYP3A4—Doxycycline—malaria	0.0647	0.0933	CbGbCtD
Dihydroergotamine—ABCB1—Quinidine—malaria	0.0645	0.093	CbGbCtD
Dihydroergotamine—CYP3A4—Quinine—malaria	0.044	0.0634	CbGbCtD
Dihydroergotamine—CYP3A4—Quinidine—malaria	0.0386	0.0557	CbGbCtD
Dihydroergotamine—CYP3A4—Dapsone—malaria	0.0333	0.0481	CbGbCtD
Dihydroergotamine—Photophobia—Quinine—malaria	0.00233	0.00812	CcSEcCtD
Dihydroergotamine—Photophobia—Quinidine—malaria	0.00233	0.00812	CcSEcCtD
Dihydroergotamine—Ventricular tachycardia—Quinidine barbiturate—malaria	0.00224	0.00781	CcSEcCtD
Dihydroergotamine—Anorexia—Pyrimethamine—malaria	0.00223	0.00779	CcSEcCtD
Dihydroergotamine—HTR1A—blood plasma—malaria	0.00218	0.111	CbGeAlD
Dihydroergotamine—Salivary hypersecretion—Pentoxifylline—malaria	0.00217	0.00757	CcSEcCtD
Dihydroergotamine—Influenza like illness—Pentoxifylline—malaria	0.00217	0.00757	CcSEcCtD
Dihydroergotamine—Depressed level of consciousness—Quinidine barbiturate—malaria	0.00216	0.00754	CcSEcCtD
Dihydroergotamine—Photophobia—Quinidine barbiturate—malaria	0.0021	0.00733	CcSEcCtD
Dihydroergotamine—Swelling—Clindamycin—malaria	0.00208	0.00725	CcSEcCtD
Dihydroergotamine—Decreased appetite—Pyrimethamine—malaria	0.00204	0.0071	CcSEcCtD
Dihydroergotamine—Hyperkinesia—Quinidine barbiturate—malaria	0.00195	0.00681	CcSEcCtD
Dihydroergotamine—Mental disability—Quinidine barbiturate—malaria	0.00194	0.00677	CcSEcCtD
Dihydroergotamine—Ear pain—Pentoxifylline—malaria	0.0019	0.00663	CcSEcCtD
Dihydroergotamine—Swelling—Pentoxifylline—malaria	0.00184	0.00641	CcSEcCtD
Dihydroergotamine—Anorexia—Proguanil—malaria	0.00174	0.00607	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Pyrimethamine—malaria	0.00173	0.00602	CcSEcCtD
Dihydroergotamine—Muscular weakness—Dapsone—malaria	0.00167	0.00584	CcSEcCtD
Dihydroergotamine—Cramp muscle—Clindamycin—malaria	0.00165	0.00576	CcSEcCtD
Dihydroergotamine—Tinnitus—Sulfadiazine—malaria	0.00159	0.00554	CcSEcCtD
Dihydroergotamine—Muscular weakness—Quinidine—malaria	0.00159	0.00554	CcSEcCtD
Dihydroergotamine—Muscular weakness—Quinine—malaria	0.00159	0.00554	CcSEcCtD
Dihydroergotamine—Decreased appetite—Proguanil—malaria	0.00159	0.00553	CcSEcCtD
Dihydroergotamine—Bronchospasm—Quinine—malaria	0.00153	0.00534	CcSEcCtD
Dihydroergotamine—Bronchospasm—Quinidine—malaria	0.00153	0.00534	CcSEcCtD
Dihydroergotamine—Chills—Sulfadiazine—malaria	0.00153	0.00534	CcSEcCtD
Dihydroergotamine—ADRA2A—blood plasma—malaria	0.00153	0.0776	CbGeAlD
Dihydroergotamine—Angina pectoris—Quinine—malaria	0.00152	0.00529	CcSEcCtD
Dihydroergotamine—Angina pectoris—Quinidine—malaria	0.00152	0.00529	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Proguanil—malaria	0.00149	0.0052	CcSEcCtD
Dihydroergotamine—Vomiting—Pyrimethamine—malaria	0.00149	0.00519	CcSEcCtD
Dihydroergotamine—Upper respiratory tract infection—Clindamycin—malaria	0.00147	0.00514	CcSEcCtD
Dihydroergotamine—Body temperature increased—Proguanil—malaria	0.00144	0.00503	CcSEcCtD
Dihydroergotamine—Abdominal pain—Proguanil—malaria	0.00144	0.00503	CcSEcCtD
Dihydroergotamine—Muscular weakness—Quinidine barbiturate—malaria	0.00143	0.005	CcSEcCtD
Dihydroergotamine—Bronchospasm—Quinidine barbiturate—malaria	0.00138	0.00482	CcSEcCtD
Dihydroergotamine—Bronchospasm—Pentoxifylline—malaria	0.00138	0.00481	CcSEcCtD
Dihydroergotamine—Sinusitis—Dapsone—malaria	0.00137	0.00478	CcSEcCtD
Dihydroergotamine—Angina pectoris—Quinidine barbiturate—malaria	0.00137	0.00477	CcSEcCtD
Dihydroergotamine—Angina pectoris—Pentoxifylline—malaria	0.00137	0.00476	CcSEcCtD
Dihydroergotamine—Epistaxis—Clindamycin—malaria	0.00133	0.00465	CcSEcCtD
Dihydroergotamine—Vertigo—Sulfadiazine—malaria	0.00133	0.00465	CcSEcCtD
Dihydroergotamine—Pharyngitis—Dapsone—malaria	0.0013	0.00454	CcSEcCtD
Dihydroergotamine—Arthralgia—Sulfadiazine—malaria	0.00126	0.00441	CcSEcCtD
Dihydroergotamine—Diarrhoea—Proguanil—malaria	0.00125	0.00435	CcSEcCtD
Dihydroergotamine—Tinnitus—Dapsone—malaria	0.00122	0.00427	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Pentoxifylline—malaria	0.00122	0.00424	CcSEcCtD
Dihydroergotamine—HTR1A—hematopoietic system—malaria	0.00121	0.0612	CbGeAlD
Dihydroergotamine—CYP3A4—blood plasma—malaria	0.0012	0.0611	CbGeAlD
Dihydroergotamine—Visual impairment—Quinidine—malaria	0.0012	0.00419	CcSEcCtD
Dihydroergotamine—Visual impairment—Quinine—malaria	0.0012	0.00419	CcSEcCtD
Dihydroergotamine—HTR1D—kidney—malaria	0.00119	0.0602	CbGeAlD
Dihydroergotamine—Epistaxis—Pentoxifylline—malaria	0.00118	0.00411	CcSEcCtD
Dihydroergotamine—Flushing—Clindamycin—malaria	0.00118	0.00411	CcSEcCtD
Dihydroergotamine—Tinnitus—Quinine—malaria	0.00116	0.00405	CcSEcCtD
Dihydroergotamine—Tinnitus—Quinidine—malaria	0.00116	0.00405	CcSEcCtD
Dihydroergotamine—Vomiting—Proguanil—malaria	0.00116	0.00405	CcSEcCtD
Dihydroergotamine—Flushing—Quinidine—malaria	0.00116	0.00403	CcSEcCtD
Dihydroergotamine—Flushing—Quinine—malaria	0.00116	0.00403	CcSEcCtD
Dihydroergotamine—Anorexia—Sulfadiazine—malaria	0.00116	0.00403	CcSEcCtD
Dihydroergotamine—Rash—Proguanil—malaria	0.00115	0.00401	CcSEcCtD
Dihydroergotamine—Dermatitis—Proguanil—malaria	0.00115	0.00401	CcSEcCtD
Dihydroergotamine—Headache—Proguanil—malaria	0.00114	0.00399	CcSEcCtD
Dihydroergotamine—Chills—Quinidine—malaria	0.00112	0.0039	CcSEcCtD
Dihydroergotamine—Chills—Quinine—malaria	0.00112	0.0039	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Sulfadiazine—malaria	0.0011	0.00385	CcSEcCtD
Dihydroergotamine—Insomnia—Sulfadiazine—malaria	0.0011	0.00382	CcSEcCtD
Dihydroergotamine—Nausea—Proguanil—malaria	0.00108	0.00378	CcSEcCtD
Dihydroergotamine—Visual impairment—Quinidine barbiturate—malaria	0.00108	0.00378	CcSEcCtD
Dihydroergotamine—Muscle spasms—Clindamycin—malaria	0.00106	0.00371	CcSEcCtD
Dihydroergotamine—Decreased appetite—Sulfadiazine—malaria	0.00105	0.00367	CcSEcCtD
Dihydroergotamine—Tinnitus—Quinidine barbiturate—malaria	0.00105	0.00366	CcSEcCtD
Dihydroergotamine—Flushing—Quinidine barbiturate—malaria	0.00104	0.00364	CcSEcCtD
Dihydroergotamine—Flushing—Pentoxifylline—malaria	0.00104	0.00363	CcSEcCtD
Dihydroergotamine—Vertigo—Dapsone—malaria	0.00103	0.00358	CcSEcCtD
Dihydroergotamine—HTR6—brain—malaria	0.00102	0.0517	CbGeAlD
Dihydroergotamine—Tremor—Quinidine—malaria	0.00102	0.00354	CcSEcCtD
Dihydroergotamine—Tremor—Quinine—malaria	0.00102	0.00354	CcSEcCtD
Dihydroergotamine—Chills—Quinidine barbiturate—malaria	0.00101	0.00352	CcSEcCtD
Dihydroergotamine—Agitation—Quinidine—malaria	0.000997	0.00347	CcSEcCtD
Dihydroergotamine—Agitation—Quinine—malaria	0.000997	0.00347	CcSEcCtD
Dihydroergotamine—Vertigo—Clindamycin—malaria	0.000993	0.00346	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Sulfadiazine—malaria	0.000991	0.00345	CcSEcCtD
Dihydroergotamine—Vertigo—Quinidine—malaria	0.000975	0.0034	CcSEcCtD
Dihydroergotamine—Vertigo—Quinine—malaria	0.000975	0.0034	CcSEcCtD
Dihydroergotamine—Urticaria—Sulfadiazine—malaria	0.000963	0.00336	CcSEcCtD
Dihydroergotamine—Tension—Quinidine barbiturate—malaria	0.000961	0.00335	CcSEcCtD
Dihydroergotamine—Tension—Pentoxifylline—malaria	0.000959	0.00334	CcSEcCtD
Dihydroergotamine—Palpitations—Quinine—malaria	0.000959	0.00334	CcSEcCtD
Dihydroergotamine—Palpitations—Quinidine—malaria	0.000959	0.00334	CcSEcCtD
Dihydroergotamine—Abdominal pain—Sulfadiazine—malaria	0.000958	0.00334	CcSEcCtD
Dihydroergotamine—Body temperature increased—Sulfadiazine—malaria	0.000958	0.00334	CcSEcCtD
Dihydroergotamine—Hypertension—Clindamycin—malaria	0.000955	0.00333	CcSEcCtD
Dihydroergotamine—Nervousness—Quinidine barbiturate—malaria	0.000951	0.00331	CcSEcCtD
Dihydroergotamine—Nervousness—Pentoxifylline—malaria	0.000949	0.00331	CcSEcCtD
Dihydroergotamine—Muscle spasms—Pentoxifylline—malaria	0.000939	0.00327	CcSEcCtD
Dihydroergotamine—HTR2B—digestive system—malaria	0.000937	0.0475	CbGeAlD
Dihydroergotamine—Discomfort—Clindamycin—malaria	0.00093	0.00324	CcSEcCtD
Dihydroergotamine—Myalgia—Quinine—malaria	0.000923	0.00322	CcSEcCtD
Dihydroergotamine—Myalgia—Quinidine—malaria	0.000923	0.00322	CcSEcCtD
Dihydroergotamine—Tremor—Quinidine barbiturate—malaria	0.000917	0.0032	CcSEcCtD
Dihydroergotamine—Tremor—Pentoxifylline—malaria	0.000915	0.00319	CcSEcCtD
Dihydroergotamine—Tachycardia—Dapsone—malaria	0.00091	0.00317	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Pentoxifylline—malaria	0.000907	0.00316	CcSEcCtD
Dihydroergotamine—Agitation—Quinidine barbiturate—malaria	0.0009	0.00314	CcSEcCtD
Dihydroergotamine—Agitation—Pentoxifylline—malaria	0.000898	0.00313	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Sulfadiazine—malaria	0.000893	0.00311	CcSEcCtD
Dihydroergotamine—Confusional state—Quinidine—malaria	0.000893	0.00311	CcSEcCtD
Dihydroergotamine—Confusional state—Quinine—malaria	0.000893	0.00311	CcSEcCtD
Dihydroergotamine—HTR2B—blood—malaria	0.000892	0.0453	CbGeAlD
Dihydroergotamine—Oedema—Quinine—malaria	0.000885	0.00309	CcSEcCtD
Dihydroergotamine—Oedema—Quinidine—malaria	0.000885	0.00309	CcSEcCtD
Dihydroergotamine—Malaise—Pentoxifylline—malaria	0.000881	0.00307	CcSEcCtD
Dihydroergotamine—Vertigo—Quinidine barbiturate—malaria	0.000879	0.00307	CcSEcCtD
Dihydroergotamine—Shock—Quinidine—malaria	0.000871	0.00304	CcSEcCtD
Dihydroergotamine—Shock—Quinine—malaria	0.000871	0.00304	CcSEcCtD
Dihydroergotamine—Palpitations—Quinidine barbiturate—malaria	0.000865	0.00302	CcSEcCtD
Dihydroergotamine—Tachycardia—Quinidine—malaria	0.000864	0.00301	CcSEcCtD
Dihydroergotamine—Tachycardia—Quinine—malaria	0.000864	0.00301	CcSEcCtD
Dihydroergotamine—Palpitations—Pentoxifylline—malaria	0.000863	0.00301	CcSEcCtD
Dihydroergotamine—Pruritus—Sulfadiazine—malaria	0.000857	0.00299	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Quinidine—malaria	0.000856	0.00298	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Quinine—malaria	0.000856	0.00298	CcSEcCtD
Dihydroergotamine—ABCB1—blood plasma—malaria	0.000852	0.0432	CbGeAlD
Dihydroergotamine—ADRA2A—hematopoietic system—malaria	0.000846	0.0429	CbGeAlD
Dihydroergotamine—Anorexia—Quinidine—malaria	0.000844	0.00294	CcSEcCtD
Dihydroergotamine—Anorexia—Quinine—malaria	0.000844	0.00294	CcSEcCtD
Dihydroergotamine—Insomnia—Dapsone—malaria	0.000844	0.00294	CcSEcCtD
Dihydroergotamine—Hypertension—Pentoxifylline—malaria	0.000844	0.00294	CcSEcCtD
Dihydroergotamine—Hypotension—Clindamycin—malaria	0.000843	0.00294	CcSEcCtD
Dihydroergotamine—Myalgia—Quinidine barbiturate—malaria	0.000833	0.00291	CcSEcCtD
Dihydroergotamine—Arthralgia—Quinidine barbiturate—malaria	0.000833	0.00291	CcSEcCtD
Dihydroergotamine—Myalgia—Pentoxifylline—malaria	0.000832	0.0029	CcSEcCtD
Dihydroergotamine—Anxiety—Quinidine barbiturate—malaria	0.000831	0.0029	CcSEcCtD
Dihydroergotamine—Diarrhoea—Sulfadiazine—malaria	0.000829	0.00289	CcSEcCtD
Dihydroergotamine—Anxiety—Pentoxifylline—malaria	0.000829	0.00289	CcSEcCtD
Dihydroergotamine—Hypotension—Quinidine—malaria	0.000827	0.00288	CcSEcCtD
Dihydroergotamine—Hypotension—Quinine—malaria	0.000827	0.00288	CcSEcCtD
Dihydroergotamine—Discomfort—Pentoxifylline—malaria	0.000822	0.00287	CcSEcCtD
Dihydroergotamine—Dry mouth—Pentoxifylline—malaria	0.000814	0.00284	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Quinidine—malaria	0.000807	0.00281	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Quinine—malaria	0.000807	0.00281	CcSEcCtD
Dihydroergotamine—Confusional state—Quinidine barbiturate—malaria	0.000806	0.00281	CcSEcCtD
Dihydroergotamine—Dyspnoea—Clindamycin—malaria	0.000804	0.0028	CcSEcCtD
Dihydroergotamine—Confusional state—Pentoxifylline—malaria	0.000804	0.0028	CcSEcCtD
Dihydroergotamine—Oedema—Quinidine barbiturate—malaria	0.000799	0.00279	CcSEcCtD
Dihydroergotamine—Oedema—Pentoxifylline—malaria	0.000797	0.00278	CcSEcCtD
Dihydroergotamine—Dyspepsia—Clindamycin—malaria	0.000794	0.00277	CcSEcCtD
Dihydroergotamine—Dyspnoea—Quinine—malaria	0.000789	0.00275	CcSEcCtD
Dihydroergotamine—Dyspnoea—Quinidine—malaria	0.000789	0.00275	CcSEcCtD
Dihydroergotamine—Shock—Quinidine barbiturate—malaria	0.000786	0.00274	CcSEcCtD
Dihydroergotamine—Shock—Pentoxifylline—malaria	0.000785	0.00274	CcSEcCtD
Dihydroergotamine—Tachycardia—Quinidine barbiturate—malaria	0.00078	0.00272	CcSEcCtD
Dihydroergotamine—Tachycardia—Pentoxifylline—malaria	0.000778	0.00271	CcSEcCtD
Dihydroergotamine—Fatigue—Clindamycin—malaria	0.000778	0.00271	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Quinidine barbiturate—malaria	0.000772	0.00269	CcSEcCtD
Dihydroergotamine—Pain—Clindamycin—malaria	0.000772	0.00269	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Pentoxifylline—malaria	0.000771	0.00269	CcSEcCtD
Dihydroergotamine—Vomiting—Sulfadiazine—malaria	0.00077	0.00269	CcSEcCtD
Dihydroergotamine—Decreased appetite—Quinidine—malaria	0.00077	0.00268	CcSEcCtD
Dihydroergotamine—Decreased appetite—Quinine—malaria	0.00077	0.00268	CcSEcCtD
Dihydroergotamine—Rash—Sulfadiazine—malaria	0.000764	0.00266	CcSEcCtD
Dihydroergotamine—Dermatitis—Sulfadiazine—malaria	0.000763	0.00266	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Dapsone—malaria	0.000763	0.00266	CcSEcCtD
Dihydroergotamine—Anorexia—Quinidine barbiturate—malaria	0.000762	0.00265	CcSEcCtD
Dihydroergotamine—Anorexia—Pentoxifylline—malaria	0.00076	0.00265	CcSEcCtD
Dihydroergotamine—Headache—Sulfadiazine—malaria	0.000759	0.00265	CcSEcCtD
Dihydroergotamine—Hypotension—Quinidine barbiturate—malaria	0.000747	0.0026	CcSEcCtD
Dihydroergotamine—Hypotension—Pentoxifylline—malaria	0.000745	0.0026	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Clindamycin—malaria	0.000738	0.00257	CcSEcCtD
Dihydroergotamine—Body temperature increased—Dapsone—malaria	0.000737	0.00257	CcSEcCtD
Dihydroergotamine—Abdominal pain—Dapsone—malaria	0.000737	0.00257	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Quinidine—malaria	0.000729	0.00254	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Quinine—malaria	0.000729	0.00254	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000728	0.00254	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000727	0.00253	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Quinidine—malaria	0.000724	0.00252	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Quinine—malaria	0.000724	0.00252	CcSEcCtD
Dihydroergotamine—Insomnia—Pentoxifylline—malaria	0.000721	0.00251	CcSEcCtD
Dihydroergotamine—Nausea—Sulfadiazine—malaria	0.00072	0.00251	CcSEcCtD
Dihydroergotamine—Urticaria—Clindamycin—malaria	0.000717	0.0025	CcSEcCtD
Dihydroergotamine—Abdominal pain—Clindamycin—malaria	0.000713	0.00249	CcSEcCtD
Dihydroergotamine—Body temperature increased—Clindamycin—malaria	0.000713	0.00249	CcSEcCtD
Dihydroergotamine—Dyspnoea—Quinidine barbiturate—malaria	0.000712	0.00248	CcSEcCtD
Dihydroergotamine—Dyspnoea—Pentoxifylline—malaria	0.000711	0.00248	CcSEcCtD
Dihydroergotamine—Somnolence—Quinidine barbiturate—malaria	0.00071	0.00248	CcSEcCtD
Dihydroergotamine—Somnolence—Pentoxifylline—malaria	0.000709	0.00247	CcSEcCtD
Dihydroergotamine—Urticaria—Quinine—malaria	0.000703	0.00245	CcSEcCtD
Dihydroergotamine—Urticaria—Quinidine—malaria	0.000703	0.00245	CcSEcCtD
Dihydroergotamine—Dyspepsia—Pentoxifylline—malaria	0.000702	0.00245	CcSEcCtD
Dihydroergotamine—Body temperature increased—Quinine—malaria	0.0007	0.00244	CcSEcCtD
Dihydroergotamine—Abdominal pain—Quinine—malaria	0.0007	0.00244	CcSEcCtD
Dihydroergotamine—Abdominal pain—Quinidine—malaria	0.0007	0.00244	CcSEcCtD
Dihydroergotamine—Body temperature increased—Quinidine—malaria	0.0007	0.00244	CcSEcCtD
Dihydroergotamine—Decreased appetite—Quinidine barbiturate—malaria	0.000694	0.00242	CcSEcCtD
Dihydroergotamine—Decreased appetite—Pentoxifylline—malaria	0.000693	0.00242	CcSEcCtD
Dihydroergotamine—Pain—Quinidine barbiturate—malaria	0.000683	0.00238	CcSEcCtD
Dihydroergotamine—CYP3A4—hematopoietic system—malaria	0.000666	0.0338	CbGeAlD
Dihydroergotamine—Hypersensitivity—Clindamycin—malaria	0.000665	0.00232	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Quinidine barbiturate—malaria	0.000658	0.0023	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Pentoxifylline—malaria	0.000657	0.00229	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000653	0.00228	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Quinidine—malaria	0.000652	0.00227	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Quinine—malaria	0.000652	0.00227	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Pentoxifylline—malaria	0.000652	0.00227	CcSEcCtD
Dihydroergotamine—Asthenia—Clindamycin—malaria	0.000647	0.00226	CcSEcCtD
Dihydroergotamine—Pruritus—Clindamycin—malaria	0.000638	0.00223	CcSEcCtD
Dihydroergotamine—Asthenia—Quinidine—malaria	0.000635	0.00221	CcSEcCtD
Dihydroergotamine—Asthenia—Quinine—malaria	0.000635	0.00221	CcSEcCtD
Dihydroergotamine—Urticaria—Quinidine barbiturate—malaria	0.000635	0.00221	CcSEcCtD
Dihydroergotamine—Urticaria—Pentoxifylline—malaria	0.000634	0.00221	CcSEcCtD
Dihydroergotamine—Body temperature increased—Quinidine barbiturate—malaria	0.000632	0.0022	CcSEcCtD
Dihydroergotamine—Abdominal pain—Quinidine barbiturate—malaria	0.000632	0.0022	CcSEcCtD
Dihydroergotamine—Abdominal pain—Pentoxifylline—malaria	0.00063	0.0022	CcSEcCtD
Dihydroergotamine—Body temperature increased—Pentoxifylline—malaria	0.00063	0.0022	CcSEcCtD
Dihydroergotamine—Pruritus—Quinine—malaria	0.000626	0.00218	CcSEcCtD
Dihydroergotamine—Pruritus—Quinidine—malaria	0.000626	0.00218	CcSEcCtD
Dihydroergotamine—Diarrhoea—Clindamycin—malaria	0.000617	0.00215	CcSEcCtD
Dihydroergotamine—HTR1B—brain—malaria	0.000615	0.0312	CbGeAlD
Dihydroergotamine—Diarrhoea—Quinidine—malaria	0.000606	0.00211	CcSEcCtD
Dihydroergotamine—Diarrhoea—Quinine—malaria	0.000606	0.00211	CcSEcCtD
Dihydroergotamine—Dizziness—Clindamycin—malaria	0.000597	0.00208	CcSEcCtD
Dihydroergotamine—HTR1D—brain—malaria	0.000595	0.0302	CbGeAlD
Dihydroergotamine—Vomiting—Dapsone—malaria	0.000593	0.00207	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Quinidine barbiturate—malaria	0.000589	0.00205	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Pentoxifylline—malaria	0.000588	0.00205	CcSEcCtD
Dihydroergotamine—Dizziness—Quinine—malaria	0.000585	0.00204	CcSEcCtD
Dihydroergotamine—Dizziness—Quinidine—malaria	0.000585	0.00204	CcSEcCtD
Dihydroergotamine—Headache—Dapsone—malaria	0.000584	0.00204	CcSEcCtD
Dihydroergotamine—Vomiting—Clindamycin—malaria	0.000574	0.002	CcSEcCtD
Dihydroergotamine—Asthenia—Quinidine barbiturate—malaria	0.000573	0.002	CcSEcCtD
Dihydroergotamine—Asthenia—Pentoxifylline—malaria	0.000572	0.00199	CcSEcCtD
Dihydroergotamine—Rash—Clindamycin—malaria	0.000569	0.00198	CcSEcCtD
Dihydroergotamine—Dermatitis—Clindamycin—malaria	0.000568	0.00198	CcSEcCtD
Dihydroergotamine—Headache—Clindamycin—malaria	0.000565	0.00197	CcSEcCtD
Dihydroergotamine—Pruritus—Quinidine barbiturate—malaria	0.000565	0.00197	CcSEcCtD
Dihydroergotamine—Pruritus—Pentoxifylline—malaria	0.000564	0.00197	CcSEcCtD
Dihydroergotamine—Vomiting—Quinine—malaria	0.000563	0.00196	CcSEcCtD
Dihydroergotamine—Vomiting—Quinidine—malaria	0.000563	0.00196	CcSEcCtD
Dihydroergotamine—ADRA2A—blood—malaria	0.00056	0.0284	CbGeAlD
Dihydroergotamine—Rash—Quinidine—malaria	0.000558	0.00195	CcSEcCtD
Dihydroergotamine—Rash—Quinine—malaria	0.000558	0.00195	CcSEcCtD
Dihydroergotamine—Dermatitis—Quinidine—malaria	0.000558	0.00194	CcSEcCtD
Dihydroergotamine—Dermatitis—Quinine—malaria	0.000558	0.00194	CcSEcCtD
Dihydroergotamine—Headache—Quinidine—malaria	0.000555	0.00193	CcSEcCtD
Dihydroergotamine—Headache—Quinine—malaria	0.000555	0.00193	CcSEcCtD
Dihydroergotamine—Nausea—Dapsone—malaria	0.000554	0.00193	CcSEcCtD
Dihydroergotamine—HTR2B—brain—malaria	0.000554	0.0281	CbGeAlD
Dihydroergotamine—Diarrhoea—Quinidine barbiturate—malaria	0.000547	0.00191	CcSEcCtD
Dihydroergotamine—CYP3A4—kidney—malaria	0.000546	0.0277	CbGeAlD
Dihydroergotamine—Diarrhoea—Pentoxifylline—malaria	0.000546	0.0019	CcSEcCtD
Dihydroergotamine—Nausea—Clindamycin—malaria	0.000536	0.00187	CcSEcCtD
Dihydroergotamine—Dizziness—Quinidine barbiturate—malaria	0.000528	0.00184	CcSEcCtD
Dihydroergotamine—Dizziness—Pentoxifylline—malaria	0.000527	0.00184	CcSEcCtD
Dihydroergotamine—Nausea—Quinine—malaria	0.000526	0.00183	CcSEcCtD
Dihydroergotamine—Nausea—Quinidine—malaria	0.000526	0.00183	CcSEcCtD
Dihydroergotamine—Vomiting—Quinidine barbiturate—malaria	0.000508	0.00177	CcSEcCtD
Dihydroergotamine—Vomiting—Pentoxifylline—malaria	0.000507	0.00177	CcSEcCtD
Dihydroergotamine—Rash—Quinidine barbiturate—malaria	0.000504	0.00176	CcSEcCtD
Dihydroergotamine—Dermatitis—Quinidine barbiturate—malaria	0.000503	0.00175	CcSEcCtD
Dihydroergotamine—Rash—Pentoxifylline—malaria	0.000503	0.00175	CcSEcCtD
Dihydroergotamine—Dermatitis—Pentoxifylline—malaria	0.000502	0.00175	CcSEcCtD
Dihydroergotamine—Headache—Quinidine barbiturate—malaria	0.0005	0.00174	CcSEcCtD
Dihydroergotamine—Headache—Pentoxifylline—malaria	0.0005	0.00174	CcSEcCtD
Dihydroergotamine—HTR1A—brain—malaria	0.000496	0.0252	CbGeAlD
Dihydroergotamine—Nausea—Quinidine barbiturate—malaria	0.000475	0.00165	CcSEcCtD
Dihydroergotamine—Nausea—Pentoxifylline—malaria	0.000474	0.00165	CcSEcCtD
Dihydroergotamine—ABCB1—hematopoietic system—malaria	0.000471	0.0239	CbGeAlD
Dihydroergotamine—CYP3A4—digestive system—malaria	0.000463	0.0235	CbGeAlD
Dihydroergotamine—CYP3A4—blood—malaria	0.000441	0.0224	CbGeAlD
Dihydroergotamine—ABCB1—kidney—malaria	0.000386	0.0196	CbGeAlD
Dihydroergotamine—ADRA2A—brain—malaria	0.000348	0.0176	CbGeAlD
Dihydroergotamine—CYP3A4—liver—malaria	0.000345	0.0175	CbGeAlD
Dihydroergotamine—ABCB1—digestive system—malaria	0.000328	0.0166	CbGeAlD
Dihydroergotamine—ABCB1—blood—malaria	0.000312	0.0158	CbGeAlD
Dihydroergotamine—ABCB1—bone marrow—malaria	0.000302	0.0153	CbGeAlD
Dihydroergotamine—ABCB1—liver—malaria	0.000244	0.0124	CbGeAlD
Dihydroergotamine—ABCB1—brain—malaria	0.000194	0.00983	CbGeAlD
